Skip to main content
Clinical Trials/CTRI/2024/03/063477
CTRI/2024/03/063477
Not yet recruiting
Phase 2

Comparative study of efficacy and safety profile of topical minoxidil 5% versus oral minoxidil 2.5 mg in patients with androgenetic alopecia in tertiary care teaching hospital,Haldwani,Uttarakhand. - NI

Dr Sally Rajkumari0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L649- Androgenic alopecia, unspecified
Sponsor
Dr Sally Rajkumari
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Sally Rajkumari

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients Of either sex with androgenetic alopecia ( Males\- Stage 1 To 4 Of Hamilton\-Norwood Scale; Females\- Stage 1 And 2 Of Ludwig Scale).
  • 2\. Age 18 years and above.
  • 3\. Patients In good general health with no evidence of systemic illness.
  • 4\. Patients who will give written informed consent.

Exclusion Criteria

  • 1\. Pregnant And lactating women.
  • 2\. Children less than 18 years.
  • 3\. Patients with systemic disease( PCOD, cardiac patients, epileptic, cancer,etc.)
  • 4\. Patients with active scalp infection, seborrheic dermatitis.
  • 5\. Patients with alopecia other than androgenetic alopecia.
  • 6\. Patients with history of surgical correction of scalp hair.
  • 7\. Drug allergy.

Outcomes

Primary Outcomes

Not specified

Similar Trials